Squarepoint
APGE icon

Squarepoint’s Apogee Therapeutics APGE Stock Holding History

Squarepoint’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.23M Buy
+38,348
New +$2.78M ﹤0.01% 1830
2025
Q2 		– Sell
-16,232
Closed -$606K – 4460
2025
Q1 		$606K Sell
16,232
-20,112
-55% -$778K ﹤0.01% 3119
2024
Q4 		$1.65M Buy
36,344
+17,301
+91% +$882K ﹤0.01% 2594
2024
Q3 		$1.12M Sell
19,043
-24,979
-57% -$1.2M ﹤0.01% 2519
2024
Q2 		$1.73M Buy
44,022
+25,829
+142% +$1.25M ﹤0.01% 2156
2024
Q1 		$1.21M Buy
+18,193
New +$794K ﹤0.01% 2452

Other funds holding APGE

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return